Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand disease

Haemophilia

Volumn 18, Issue 2, 2012, Pages 200-204

  Santoro, C ^a   Hsu, F ^a   Dimichele, D M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Adenotonsillectomy; DDAVP; Desmopressin acetate; EACA; Epsilon aminocaproic acid; Von Willebrand disease

Indexed keywords

AMINOCAPROIC ACID; DESMOPRESSIN ACETATE;

ADENOTONSILLECTOMY; ADOLESCENT; ARTICLE; BLEEDING; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEMOSTASIS; HUMAN; INFANT; MALE; MEDICAL RECORD REVIEW; PATIENT COMPLIANCE; POSTOPERATIVE HEMORRHAGE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE DRUG DOSE; VON WILLEBRAND DISEASE;

6-AMINOCAPROIC ACID; ADENOIDECTOMY; ADOLESCENT; ANTIFIBRINOLYTIC AGENTS; CHILD; CHILD, PRESCHOOL; DEAMINO ARGININE VASOPRESSIN; DELAYED-ACTION PREPARATIONS; FEMALE; HEMOSTATICS; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; TONSILLECTOMY; VON WILLEBRAND DISEASE, TYPE 1;

EID: 84857120030     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02619.x     Document Type: Article

References (23)

1. Lowe D, van der Meulen J, Cromwell D et al. Key messages from the National Prospective Tonsillectomy Audit. Laryngoscope 2007; 117: 717-24.
2. Schmidt R, Herzog A, Cook S, O'Reilly R, Deutsch E, Reilly J. Complications of tonsillectomy: a comparison of techniques. Arch Otolaryngol Head Neck Surg 2007; 133: 925-8.
3. Windfuhr JP, Chen YS, Remmert S. Hemorrhage following tonsillectomy and adenoidectomy in 15, 218 patients. Otolaryngol Head Neck Surg 2005; 132: 281-6.
4. Tomkinson A, De Martin S, Gilchrist CR, Temple M. Instrumentation and patient characteristics that influence postoperative haemorrhage rates following tonsil and adenoid surgery. Clin Otolaryngol 2005; 30: 338-46.
5. Krishna P, Lee D. Post-tonsillectomy bleeding: a meta-analysis. Laryngoscope 2001; 111: 1358-61.
6. Macassey EA, Baguley C, Dawes P, Gray A. 15-year audit of post-tonsillectomy haemorrhage at Dunedin Hospital. ANZ J Surg 2007; 77:579-82.
7. Witmer CM, Elden L, Butler RB, Manno CS, Raffini LJ. Incidence of bleeding complications in pediatric patients with type 1 von Willebrand disease undergoing adenotonsillar procedures. J Pediatr 2009; 155: 68-72.
8. Rodriguez KD, Sun GH, Pike F, Mandel EM, Casselbrant ML, Chi DH. Post-tonsillectomy bleeding in children with von Willebrand disease: a single-institution experience. Otolaryngol Head Neck Surg 2010; 142: 715-21.
9. Woods AI, Blanco AN, Chuit R et al. Major haemorrhage related to surgery in patients with type 1 and possible type 1 von Willebrand disease. Thromb Haemos 2008; 100: 797-802.
10. Allen GC, Armfield DR, Bontempo FA, Kingsley LA, Goldstein NA, Post JC. Adenotonsillectomy in children with von Willebrand disease. Arch Otolaryngol Head Neck Surg 1999; 125: 547-51.
11. Mannucci PM, Franchini M, Castaman G, Federici AB, Italian Association of Hemophilia Centers. Evidence-based recommendations on the treatment of von Willebrand disease in Italy. Blood Transfus 2009; 7: 117-26.
12. Castaman G, Lethagen S, Federici AB et al. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood 2008; 111: 3531-9.
13. Federici AB. Use of desmopressin in von Willebrand disease: the experience of the first 30years (1977-2007). Haemophilia 2008; 14(Suppl 1): 5-14.
14. Smith TJ, Gill JC, Ambruso DR, Hathaway WE. Hyponatremia and seizures in young children given DDAVP. Am J Hemato. 1989; 31: 199-202.
15. Shah SB, Lalwani AK, Koerper MA. Perioperative management of von Willebrand's disease in otolaryngologic surgery. Laryngoscope 1998; 108: 32-6.
16. Derkay CS, Werner E, Plotnick E. Management of children with von Willebrand disease undergoing adenotonsillectomy. Am J Otolaryngol 1996; 17: 172-7.
17. Jiménez-Yuste V, Prim MP, De Diego JI et al. Otolaryngologic surgery in children with von Willebrand disease. Arch Otolaryngol Head Neck Surg 2002; 128: 1365-8.
18. Sánchez-Luceros A, Meschengieser S, Woods AI et al. Biological and clinical response to desmopressin (DDAVP) in a retrospective cohort study of children with low von Willebrand factor levels and bleeding history. Thromb Haemost 2010; 104: 984/9.
19. Nichols WL, Hultin MB, James AH et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008; 14:171-232.
20. Federici AB, Mazurier C, Berntorp E et al. Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study. Blood 2004; 103: 2032-8.
21. Hoffman M, Monroe DM. Wound healing in haemophilia - breaking the vicious cycle. Haemophilia 2010; 16(Suppl 3): 13-8.
22. Dunn AL, Cox Gill J. Adenotonsillectomy in patients with desmopressin responsive mild bleeding disorders: a review of the literature. Haemophilia 2010; 16: 711-6.
23. Mannucci PM. Hemostatic drugs. NEJM 1998; 339: 245-53.